Antibody response after second BNT162b2 dose in allogeneic HSCT recipients. Redjoul R, Le Bouter A, Beckerich F, Fourati S, et al. Lancet 2021;398:298-299.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Redjoul R, Le Bouter A, Beckerich F, Fourati S, et al. Antibody response after second BNT162b2 dose in allogeneic HSCT recipients. Lancet 2021;398:298-299.
PMID: 34270933